Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Other solid neoplasm 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Solid Tumor 3Advanced Solid Tumors 3Solid Tumors 2Solid Tumours 1Solid Tumor, Adult 1Sarcoma, Synovial 1Sarcoma 1Rhabdoid Tumor 1Refractory or Relapsed Solid Tumors 1Mesothelioma 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Hematologic Neoplasms 1Advanced Solid Tumours 1Advanced Solid Tumor 1

Interventions

Granulocyte Colony-Stimulating Factor 3Etoposide 3tazemetostat 2Thiotepa 2Mesna 2Melphalan 2Ifosfamide 2Filgrastim 2Carboplatin 2Busulfan 2sargramostim 1pembrolizumab 1pegylated granulocyte colony-stimulating factor 1omburtamab I-131 1etoposide phosphate 1Ursodeoxycholic Acid 1Topotecan 1Stem Cell Transplantation 1Sirolimus 1Simvastatin 1Rifampin 1Radiotherapy, Intensity-Modulated 1Radiation 1Peripheral Blood Stem Cell Transplantation 1Paclitaxel 1Leukapheresis 1Itraconazole 1Immunologic Techniques 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Rhabdoid Tumor × Rifampin × Other solid neoplasm × Clear all
NCT04537715 2025-02-19

Effects of Itraconazole and Rifampin on the Blood Tazemetostat Levels

Ipsen

Phase 1 Completed
42 enrolled 39 charts
LymphoidOther hematologic neoplasmOther solid neoplasmSarcomaThoracic

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Mesothelioma, Sarcoma, Sarcoma, Synovial, Lymphoma, Large B-Cell, Diffuse, Rhabdoid Tumor, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡